Arquivamento definitivo - Art. 33 da LPI
#11.1.1
12/17/2024
RPI 2815
Application data
Number
112023013946Type
Filing
Publication
PCT
US2021051647 The application was abandoned: examination was not requested within the 36 months following the 09/23/2021 filing, the deadline set by art. 33 of the Brazilian IP Act. The technology is in the public domain in Brazil.
Talk to a specialistLatest action published by the INPI: 12/17/2024. We update with every new RPI gazette, published weekly.
Applicants
LIXTE BIOTECHNOLOGY, INC.
US
Inventors
J. K. (pessoa física)
US
R. S. (pessoa física)
US
IPC Classification
Priority claims
US
63/139,047 · 01/19/2021
Abstract
OXABICICLO-HEPTANOS PARA O TRATAMENTO DE CÂNCER DE PULMÃO DE PEQUENAS CÉLULAS. A presente invenção fornece um método para o tratamento de um indivíduo que sofre de CPPC compreendendo a administração ao indivíduo de uma quantidade eficaz de um inibidor de PP2A e opcionalmente um ou mais agentes anticancerígenos.
Publications in the Brazilian Industrial Property Gazette (RPI).
#11.1.1
12/17/2024
RPI 2815
#11.1
10/01/2024
RPI 2804
#1.3
08/15/2023
RPI 2745
#1.1
07/25/2023
RPI 2742
From the same holder
Same category
Patent monitoring
Receive alerts on INPI events, decisions, and expiry dates for your portfolio.